Purdue Pharma fees surpass $250 million for Davis Polk amid new bankruptcy plan
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to [email protected]) ...
Morningstar20d
Purdue Pharma L.P. Files New Plan of Reorganization Providing for More Than $7.4 Billion in Creditor Distributions
About Purdue Pharma L.P. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers.
Yahoo20d
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo ...
Purdue Pharma Files New Reorganization Plan With $7.4 Billion for Creditors
Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion of cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.
Why a potential $7.4 billion Purdue Pharma opioid settlement frustrates some victims
Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy bankruptcy case says.
MercoPress19d
Tag: Purdue Pharma
U.S. states claimed they are owed US$ 2.2 trillion to address harm from OxyContin maker Purdue Pharma LP’s alleged role in America’s opioid epidemic, accusing the drug-maker in new filings of ...
CBS News29d
Statement of Purdue Pharma to 60 Minutes
Prior to 60 Minutes' March 9, 2025 broadcast, which featured correspondent Cecilia Vega's report on the Purdue Pharma bankruptcy case, we reached out to Purdue Pharma for comment on our story ...
Reuters20d
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...